PLOS Genetics study identifies SynMuvA gene lin-15A as a licensing factor for natural cellular transdifferentiation

Cellular plasticity — the capacity of a cell to change its identity — is normally tightly constrained by molecular safeguards that preserve cell fate. Understanding the mechanisms that either permit or block such plasticity has implications for cancer biology, where aberrant transdifferentiation can drive disease, and for regenerative medicine, where controlled plasticity is a therapeutic goal.

Researchers including Sarah Frieda Becker, Marie-Charlotte Morin, Julien Lambert, and colleagues — including Julie Ahringer and Sophie Jarriault — have published a study in PLOS Genetics identifying lin-15A, a THAP domain-containing gene and member of the SynMuvA class of chromatin regulators, as a factor required to licence a naturally occurring transdifferentiation event in Caenorhabditis elegans. The work shows that lin-15A achieves this by antagonising identity-safeguarding mechanisms that would otherwise prevent the cell-fate switch.

The findings extend understanding of how endogenous cellular reprogramming is normally controlled and identify a new category of pro-plasticity regulatory factor. The SynMuvA pathway has previously been linked to tumour suppression, adding context to the broader relevance of this regulatory axis.

This peer-reviewed study is of primary interest to researchers in cell biology, epigenetics, and the molecular basis of cellular plasticity, and to educators covering developmental biology and cancer.